Dr. Ungewickell is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
875 Blake Wilbur Dr
Stanford Cancer Center
Palo Alto, CA 94304Phone+1 650-498-6000Fax+1 650-498-6205
Education & Training
- Stanford Health Care-Sponsored Stanford UniversityFellowship, Hematology, 2009 - 2012
- Stanford Health Care-Sponsored Stanford UniversityResidency, Internal Medicine, 2007 - 2010
- Washington University in St. Louis School of MedicineClass of 2007
Certifications & Licensure
- CA State Medical License 2008 - 2026
- American Board of Internal Medicine Hematology
- American Board of Internal Medicine Medical Oncology
Clinical Trials
- Analysis of Cutaneous and Hematologic Disorders by High-Throughput Nucleic Acid Sequencing Start of enrollment: 2011 Jun 01
Publications & Presentations
PubMed
- 8 citationsThe HER2-directed antibody-drug conjugate DHES0815A in advanced and/or metastatic breast cancer: preclinical characterization and phase 1 trial results.Gail D Lewis, Guangmin Li, Jun Guo, Shang-Fan Yu, Carter T Fields
Nature Communications. 2024-01-11 - 47 citationsWhole-body CD8T cell visualization before and during cancer immunotherapy: a phase 1/2 trial.Laura Kist de Ruijter, Pim P van de Donk, Jahlisa S Hooiveld-Noeken, Danique Giesen, Sjoerd G Elias
Nature Medicine. 2022-12-01 - 10 citationsA Phase I study of DLYE5953A, an anti-LY6E antibody covalently linked to monomethyl auristatin E, in patients with refractory solid tumorsSara M. Tolaney, Khanh T. Do, Joseph Paul Eder, Patricia LoRusso, Colin D. Weekes
Clinical Cancer Research. 2020-07-21
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: